| 摘要: |
| ［摘要］ 急性冠脉综合征是冠心病致死和致残的主要原因之一。随着冠心病药物治疗的进展和急诊PCI技术的成熟和广泛开展，近年来急性冠脉综合征的治疗效果和预后显著改善。本文综述急性冠脉综合征治疗的最新进展。 |
| 关键词: 急性冠脉综合征 药物治疗 PCI术 |
| DOI：10.3969/j.issn.1674-3806.2009.11.44 |
| 分类号:R 541.1 |
| 基金项目: |
|
| Progress in treatment of acute coronary syndrome |
|
HU Chang-xing, XU Guang-ma
|
|
Department of Cardiology, the People′s Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China
|
| Abstract: |
| ［Abstract］ Acute coronary syndrome(ACS) is one of the primary causes of the mortality and morbidity in coronary heart disease. Recently, along with the progress of pharmacotherapy and widely application of primary percutanous coronary intervention in the treatment of coronary heart disease, the treatment effectiveness and the progress of ACS were improved significantly.This article reviews the advances in the treatment of ACS. |
| Key words: Acute coronary syndrome Pharmacotherapy Percutanous coronary intervention |
